CELAZOME  MOISTURIZING SPF 30 ACTIVE- oxybenzone, octinoxate, octisalate, and homosalate cream 
Dermazone Solutions, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

celazome®
Moisturizing SPF 30 Active

Drug Facts

Active ingredients

Benzophenone-3 5.0%
Ethylhexyl Methoxycinnamate 7.5%
Ethylhexyl Salicylate 5.0%
Homosalate 5.0%

Purpose

Sunscreen

Uses

Warnings

Skin Cancer/Skin Aging Alert

Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to prevent sunburn, not skin cancer or early skin aging.

For external use only.

Do not use on damaged or broken skin.

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs.

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

Inactive ingredients

purifed water, sorbitol, dicaprylyl maleate, alcohol, potassium cetyl phosphate, lecithin, cetyl alcohol, dimethicone, tocopheryl acetate, aloe barbadensis leaf juice, carbomer, methylparaben, propylparaben, triethanolamine

Manufactured for Celazome® by:
Dermazone Solutions
St. Petersburg, FL 33713

PRINCIPAL DISPLAY PANEL - 113 g Bottle Carton

celazome®
clinical skin care

Moisturizing Sunscreen

Clinical Skin Care with
Lyphazome® Technology

SPF 30 ACTIVE
SPORT

WATER RESISTANT
(80 MINUTES)

4 OZ (113 g)

Principal Display Panel - 113 g Bottle Carton
CELAZOME   MOISTURIZING SPF 30 ACTIVE
oxybenzone, octinoxate, octisalate, and homosalate cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58466-901
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OXYBENZONE (UNII: 95OOS7VE0Y) (OXYBENZONE - UNII:95OOS7VE0Y) OXYBENZONE50 mg  in 1 g
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE75 mg  in 1 g
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE50 mg  in 1 g
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE50 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
water (UNII: 059QF0KO0R)  
dioctyl maleate (UNII: OD88G8439L)  
alcohol (UNII: 3K9958V90M)  
sorbitol (UNII: 506T60A25R)  
Diethanolamine Cetyl Phosphate (UNII: 4UG0316V9S)  
aloe vera leaf (UNII: ZY81Z83H0X)  
.alpha.-tocopherol acetate (UNII: 9E8X80D2L0)  
dimethicone (UNII: 92RU3N3Y1O)  
cetyl alcohol (UNII: 936JST6JCN)  
trolamine (UNII: 9O3K93S3TK)  
propylparaben (UNII: Z8IX2SC1OH)  
methylparaben (UNII: A2I8C7HI9T)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58466-901-041 in 1 CARTON10/01/2015
1113 g in 1 BOTTLE, DISPENSING; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart35210/01/2015
Labeler - Dermazone Solutions, Inc. (136116865)
Establishment
NameAddressID/FEIBusiness Operations
Deramzone Solutions, Inc.136116865MANUFACTURE(58466-901)

Revised: 11/2018
Document Id: 4dd936e1-78e4-4cb3-99cf-0aad59829802
Set id: 5ec1510d-1465-4849-9e23-f16e11ff0e65
Version: 2
Effective Time: 20181116
 
Dermazone Solutions, Inc.